Hematopoietic Stem Cell Transplantation Period following HLA-Matched Subset Dominates the Early Posttransplant NK CelllowCD 16 brightAn Unusual CD 56

[1]  N. Huntington,et al.  Developmental pathways that generate natural-killer-cell diversity in mice and humans , 2007, Nature Reviews Immunology.

[2]  P. Parham,et al.  A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. , 2007, Blood.

[3]  T. Enver,et al.  CD56bright Human NK Cells Differentiate into CD56dim Cells: Role of Contact with Peripheral Fibroblasts , 2007, The Journal of Immunology.

[4]  A. Toubert,et al.  CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. , 2007, Gastroenterology.

[5]  A. Diefenbach,et al.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15. , 2007, Immunity.

[6]  A. Thiel,et al.  CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1 , 2007, The Journal of Immunology.

[7]  T. Waldmann,et al.  The IL-15/IL-15Rα on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells , 2007, Proceedings of the National Academy of Sciences.

[8]  M. Caligiuri,et al.  Human natural killer cell development , 2006, Immunological reviews.

[9]  J. D. Di Santo,et al.  Bone marrow versus thymic pathways of natural killer cell development , 2006, Immunological reviews.

[10]  M. Caligiuri,et al.  Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity. , 2006, Blood.

[11]  A. Cumano,et al.  A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127 , 2006, Nature Immunology.

[12]  C. Münz,et al.  NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN‐γ secretion , 2006 .

[13]  A. Toubert,et al.  Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders , 2006, Bone Marrow Transplantation.

[14]  T. Waldmann.  The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design , 2006, Nature Reviews Immunology.

[15]  M. Caligiuri,et al.  Human natural killer cell development and biology. , 2006, Blood reviews.

[16]  M. Caligiuri,et al.  Evidence for discrete stages of human natural killer cell differentiation in vivo , 2006, The Journal of experimental medicine.

[17]  B. Blom,et al.  Development of human lymphoid cells. , 2006, Annual review of immunology.

[18]  J. P. Santo.  NATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance , 2006 .

[19]  P. Parham,et al.  Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function , 2006, The Journal of experimental medicine.

[20]  R. Germain,et al.  Natural killer cell behavior in lymph nodes revealed by static and real-time imaging , 2006, The Journal of experimental medicine.

[21]  Z. Trajanoski,et al.  Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.

[22]  Jeffrey S. Miller,et al.  KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. , 2005, Blood.

[23]  K. Rezvani,et al.  The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions. , 2005, Blood.

[24]  D. F. Barber,et al.  Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells , 2005, The Journal of experimental medicine.

[25]  P. Debré,et al.  NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. , 2005, Blood.

[26]  Megan E. McNerney,et al.  A new self: MHC-class-I-independent Natural-killer-cell self-tolerance , 2005, Nature Reviews Immunology.

[27]  C. Le,et al.  Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. , 2005, Blood.

[28]  P. Parham.  MHC class I molecules and kirs in human history, health and survival , 2005, Nature Reviews Immunology.

[29]  M. Caligiuri,et al.  A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. , 2005, Immunity.

[30]  M. Caligiuri,et al.  Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. , 2005, Blood.

[31]  Antonio Lanzavecchia,et al.  Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming , 2004, Nature Immunology.

[32]  P. Burkett,et al.  Coordinate Expression and Trans Presentation of Interleukin (IL)-15Rα and IL-15 Supports Natural Killer Cell and Memory CD8+ T Cell Homeostasis , 2004, The Journal of experimental medicine.

[33]  C. Craddock,et al.  The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. , 2004, Blood.

[34]  H. Rammensee,et al.  Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. , 2003, Blood.

[35]  M. Caligiuri,et al.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. , 2003, Blood.

[36]  P. Parham,et al.  128Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation , 2003 .

[37]  M. Smyth,et al.  Cutting Edge: Tumor Rejection Mediated by NKG2D Receptor-Ligand Interaction Is Dependent upon Perforin1 , 2002, The Journal of Immunology.

[38]  S. Ferrone,et al.  Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. , 2002, Cancer research.

[39]  T. Waldmann,et al.  IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells , 2002 .

[40]  Markus Uhrberg,et al.  Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes , 2002, Immunogenetics.

[41]  Y. Li,et al.  IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[43]  C. Sutherland,et al.  UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells , 2002, The Journal of Immunology.

[44]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[45]  R. Biassoni,et al.  Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells , 1999, The Journal of experimental medicine.

[46]  R. Biassoni,et al.  NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells , 1999, European journal of immunology.

[47]  M. Caligiuri,et al.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. , 1999, Journal of immunology.

[48]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[49]  C. Croce,et al.  A potential role for interleukin-15 in the regulation of human natural killer cell survival. , 1997, The Journal of clinical investigation.

[50]  M. Caligiuri,et al.  Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. , 1995, The Journal of clinical investigation.

[51]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[52]  Eric O Long,et al.  Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. , 2006, Blood.

[53]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[54]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[55]  M. V. D. van den Brink,et al.  Rhamm Expression and Isoform Balance Predicts Aggressive Disease and Poor Survival in Multiple Myeloma , 2022 .